• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Model
    • Our Impact
    • Our Founder
    • Our Team
    • Our Partners
  • For Scientists
    • Research Cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
    • Funding Opportunities
    • Funded Projects
    • Annual Meeting
    • Science on Target Blog
  • Understanding ALS
    • The Science, Explained
      • Glossary
      • FAQ
      • ALS 101
    • Voices of ALS
    • Video Library
  • Take Action
    • ALS Awareness Month:
      Behind the Breakthrough
    • Support Geoff Greulich
    • The ALS Global Research Initiative (AGRI)
      • Global Natural History Study
      • Community Based Pop-Up Clinics
    • Ways to Give
    • Email Sign Up
    • Contact Us
    • Donate Now
  • News
    • Announcements
    • In the News
    • Newsletters & Reports

Neurodegenerative Disease

Letter From Our CEO: 2024 Target ALS Annual Meeting Remarks

Melissa Rentfrow · Jun 28, 2024 ·

Breakthroughs in Biomarker Research: Insights From Our 2024 Annual Meeting

Melissa Rentfrow · Jun 28, 2024 ·

Identifying Novel Drug Targets: Expanding the Horizons of ALS Treatment

Melissa Rentfrow · Jun 28, 2024 ·

The Connection Between Dysphagia and ALS

steckinsights · Jun 20, 2022 ·

connection between dysphagia and ALS

ALS Muscle Twitching vs BFS Muscle Twitching: Knowing the Differences

steckinsights · Jun 1, 2022 ·

muscle-twitching

What is Bulbar-Onset ALS? Six Things to Know.

steckinsights · May 10, 2022 ·

cells

n-Lorem Foundation and Columbia University Establish Silence ALS Initiative

steckinsights · May 3, 2022 ·

N-Lorem Foundation

ALS in the Elderly: Recognizing ALS in Seniors

steckinsights · Apr 28, 2022 ·

pushing grandmother in wheelchair

ALS and Nutrition: How Diet Impacts ALS Patients

steckinsights · Apr 8, 2022 ·

salad
  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Go to Next Page »

Footer

Target ALS
  • Donate
  • Contact
  • Financial Reports
  • Call For Proposals
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

guidestar

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140
Steck Insights WordPress Consulting

Join us this ALS Awareness Month to discover the people, stories, and science accelerating progress in ALS research.

Name(Required)
Interests(Required)
Mark the options that best describe your interest in ALS